Bristol Myers Squibb is closing a gene-therapy manufacturing facility in Libertyville that employs 133 workers. It's the second time the facility has been on the losing end of a consolidation play.

Bristol Myers Squibb has appointment Cari Gallman as executive vice president, general counsel and chief policy officer, ...

Matador Technologies (MATA.V) advanced 9.9% after it refreshed its brand identity to reflect its evolution into a vertically integrated Bitcoin-focused company. The company said its mission is to buy ...

BMS pledges $40B over five years to boost U.S. R&D, tech innovation, and pharmaceutical manufacturing under CEO Christopher ...

Bristol Myers Squibb helmsman Chris Boerner joined a growing list of life sciences leaders announcing major U.S. investments ...

The funds will reportedly be allocated for R&D, technology advancements, and enhancing domestic manufacturing capacity.

The announcement of new investment was first made by CEO Christopher Boerner in an opinion piece published in Stat News on ...

Bristol Myers Squibb will spend $40 billion in the US over the next five years, CEO Christopher Boerner wrote in an opinion ...

Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced that Dr. Helen Torley, president and chief executive ...